As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Whether the payer is a for-profit PBM in the U.S. or a single-payer government ... at “brick and mortar” pharmacies for other retail products instead of ordering the items from a convenient ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

NACDS said its first conference of 2025 kicked off with chains and suppliers working together to meet Americans’ needs.

Indeed, PBMs are a natural counterweight to big drug companies that typically charge whatever the market can bear for their products ... here is whether the PBM industry should continue to ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Even though the price to manufacture insulin and diabetes-related products has decreased, the costs of the drugs themselves have increased. Over the past 25 years, the list price of certain ...

In the meantime, the PBM industry is doing an excellent job ... These requirements may include limits on how often products can be removed from formulary; mandated coverage of certain drug classes ...